Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'STAELS B' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 147 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Delerive, P; Monte, D; Dubois, G; Trottein, F; Fruchart-Najib, J; Mariani, J; Fruchart, JC; Staels, B
      The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response

      EMBO REPORTS
    2. Duez, H; Fruchart, JC; Staels, B
      PPARs in inflammation, atherosclerosis and thrombosis

      JOURNAL OF CARDIOVASCULAR RISK
    3. Post, SM; Duez, H; Gervois, PP; Staels, B; Kuipers, F; Princen, HMG
      Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7 alpha-hydroxylaseand sterol 27-hydroxylase expression

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    4. Chinetti, G; Lestavel, S; Bocher, V; Remaley, AT; Neve, B; Torra, IP; Teissier, E; Minnich, A; Jaye, M; Duverger, N; Brewer, HB; Fruchart, JC; Clavey, V; Staels, B
      PPAR-alpha and PPAR-gamma activators induce cholesterol removal from humanmacrophage foam cells through stimulation of the ABCA1 pathway

      NATURE MEDICINE
    5. Fruchart, JC; Staels, B; Duriez, P
      PPARs, metabolic disease and atherosclerosis

      PHARMACOLOGICAL RESEARCH
    6. Torra, IP; Chinetti, G; Duval, C; Fruchart, JC; Staels, B
      Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice

      CURRENT OPINION IN LIPIDOLOGY
    7. Lestavel, S; Chinetti, G; Bocher, V; Fruchart, JC; Clavey, V; Staels, B
      Peroxisome proliferator-activated receptors in human atherosclerosis

      M S-MEDECINE SCIENCES
    8. Hourton, D; Delerive, P; Stankova, J; Staels, B; Chapman, MJ; Ninio, E
      Oxidized low-density lipoprotein and peroxisome-proliferator-activated receptor alpha down-regulate platelet-activating-factor receptor expression inhuman macrophages

      BIOCHEMICAL JOURNAL
    9. Staels, B
      Regulation of lipid and lipoprotein metabolism by retinoids

      JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
    10. Dol, F; Martin, G; Staels, B; Mares, AM; Cazaubon, C; Nisato, D; Bidouard, JP; Janiak, P; Schaeffer, P; Herbert, JM
      Angiotensin AT(1) receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    11. Lehto, M; Laitinen, S; Chinetti, G; Johansson, M; Ehnholm, C; Staels, B; Ikonen, E; Olkkonen, VM
      The OSBP-related protein family in humans

      JOURNAL OF LIPID RESEARCH
    12. Delerive, P; Fruchart, JC; Staels, B
      Peroxisome proliferator-activated receptors in inflammation control

      JOURNAL OF ENDOCRINOLOGY
    13. Martin, G; Duez, H; Blanquart, C; Berezowski, V; Poulain, P; Fruchart, JC; Najib-Fruchart, J; Glineur, C; Staels, B
      Statin-induced inhibition of the Rho-signaling pathway activates PPAR alpha and induces HDL apoA-I

      JOURNAL OF CLINICAL INVESTIGATION
    14. Dallongeville, J; Bauge, E; Tailleux, A; Peters, JM; Gonzalez, FJ; Fruchart, JC; Staels, B
      Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil

      JOURNAL OF BIOLOGICAL CHEMISTRY
    15. Morton, NM; Holmes, MC; Fievet, C; Staels, B; Tailleux, A; Mullins, JJ; Seckl, JR
      Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11 beta-hydroxysteroid dehydrogenase type 1 null mice.

      JOURNAL OF BIOLOGICAL CHEMISTRY
    16. Akiyama, TE; Nicol, CJ; Fievet, C; Staels, B; Ward, JM; Auwerx, J; Lee, SST; Gonzalez, FJ; Peters, JM
      Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity - Studies with congenic mouse lines

      JOURNAL OF BIOLOGICAL CHEMISTRY
    17. Raspe, E; Duez, H; Gervois, P; Fievet, C; Fruchart, JC; Besnard, S; Mariani, J; Tedgui, A; Staels, B
      Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor ROR alpha

      JOURNAL OF BIOLOGICAL CHEMISTRY
    18. Gervois, P; Vu-Dac, N; Kleemann, R; Kockx, M; Dubois, G; Laine, B; Kosykh, V; Fruchart, JC; Kooistra, T; Staels, B
      Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta

      JOURNAL OF BIOLOGICAL CHEMISTRY
    19. Singaraja, RR; Bocher, V; James, ER; Clee, SM; Zhang, LH; Leavitt, BR; Tan, B; Brooks-Wilson, A; Kwok, A; Bissada, N; Yang, YZ; Liu, GQ; Tafuri, SR; Fievet, C; Wellington, CL; Staels, B; Hayden, MR
      Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and apoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1

      JOURNAL OF BIOLOGICAL CHEMISTRY
    20. Bouly, M; Masson, D; Gross, B; Jiang, XC; Fievet, C; Castro, G; Tall, AR; Fruchart, JC; Staels, B; Lagrost, L; Luc, G
      Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate

      JOURNAL OF BIOLOGICAL CHEMISTRY
    21. Baroukh, N; Ostos, MA; Vergnes, L; Recalde, D; Staels, B; Fruchart, JC; Ochoa, A; Castro, G; Zakin, MM
      Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice reduces atherogenesis in response to a high fat-high cholesterol diet

      FEBS LETTERS
    22. Angeli, W; Faveeuw, C; Delerive, P; Fontaine, J; Barriera, Y; Franchimont, N; Staels, B; Capron, M; Trottein, F
      Schistosoma mansoni induces the synthesis of IL-6 in pulmonary microvascular endothelial cells: role of IL-6 in the control of lung eosinophilia during infection

      EUROPEAN JOURNAL OF IMMUNOLOGY
    23. Gosset, P; Charbonnier, AS; Delerive, P; Fontaine, J; Staels, B; Pestel, J; Tonnel, AB; Trottein, F
      Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells

      EUROPEAN JOURNAL OF IMMUNOLOGY
    24. Neve, BP; Corseaux, D; Chinetti, G; Zawadzki, C; Fruchart, JC; Duriez, P; Staels, B; Jude, B
      PPAR alpha agonists inhibit tissue factor expression in human monocytes and macrophages

      CIRCULATION
    25. Junquero, D; Pilon, A; Carilla-Durand, E; Patoiseau, JF; Tarayre, JP; Torpier, G; Staels, B; Fruchart, JC; Colpaert, FC; Clavey, V; Delhon, A
      Lack of toxic effects of F 12511, a novel potent inhibitor of acylcoenzymeA: cholesterol O-acyltransferase, on human adrenocortical cells in culture

      BIOCHEMICAL PHARMACOLOGY
    26. Fruchart, JC; Staels, B; Duriez, P
      New conceptions in the mechanism of action of fibrates and prospective therapeutics in atherosclerosis

      BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE
    27. Staels, B
      New roles for PPARs in cholesterol homeostasis

      TRENDS IN PHARMACOLOGICAL SCIENCES
    28. Gervois, P; Torra, IP; Fruchart, JC; Staels, B
      Regulation of lipid and lipoprotein metabolism by PPAR activators

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    29. Lacquemant, C; Lepretre, F; Torra, IP; Manraj, M; Charpentier, G; Ruiz, J; Staels, B; Froguel, P
      Mutation screening of the PPAR alpha gene in type 2 diabetes associated with coronary heart disease

      DIABETES & METABOLISM
    30. Chinetti, G; Fruchart, JC; Staels, B
      Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation

      INFLAMMATION RESEARCH
    31. Staels, B
      Nuclear transcription factors: new opportunities for lipid lowering

      PROCEEDINGS OF THE NUTRITION SOCIETY
    32. Delerive, P; Gervois, P; Fruchart, JC; Staels, B
      Induction of I kappa B alpha expression as a mechanism contributing to theanti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators

      JOURNAL OF BIOLOGICAL CHEMISTRY
    33. Guerre-Millo, M; Gervois, P; Raspe, E; Madsen, L; Poulain, P; Derudas, B; Herbert, JM; Winegar, DA; Willson, TM; Fruchart, JC; Berge, RK; Staels, B
      Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity

      JOURNAL OF BIOLOGICAL CHEMISTRY
    34. Faveeuw, C; Fougeray, S; Angeli, V; Fontaine, J; Chinetti, G; Gosset, P; Delerive, P; Maliszewski, C; Capron, M; Staels, B; Moser, M; Trottein, F
      Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-12 production in murine dendritic cells

      FEBS LETTERS
    35. Delerive, P; Furman, C; Teissier, E; Fruchart, JC; Duriez, P; Staels, B
      Oxidized phospholipids activate PPAR alpha in a phospholipase A2-dependentmanner

      FEBS LETTERS
    36. Torra, IP; Tsibulsky, V; Delaunay, F; Saladin, R; Laudet, V; Fruchart, JC; Kosykh, V; Staels, B
      Circadian and glucocorticoid regulation of Rev-erb alpha expression in liver

      ENDOCRINOLOGY
    37. Flavell, DM; Torra, IP; Jamshidi, Y; Evans, D; Diamond, JR; Elkeles, RS; Bujac, SR; Miller, G; Talmud, PJ; Staels, B; Humphries, SE
      Variation in the PPAR alpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects

      DIABETOLOGIA
    38. Chinetti, G; Gbaguidi, FG; Griglio, S; Mallat, Z; Antonucci, M; Poulain, P; Chapman, J; Fruchart, JC; Tedgui, A; Najib-Fruchart, J; Staels, B
      CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors

      CIRCULATION
    39. Neve, BP; Fruchart, JC; Staels, B
      Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis

      BIOCHEMICAL PHARMACOLOGY
    40. Andersson, Y; Majd, Z; Lefebvre, AM; Martin, G; Sechkin, AV; Kosykh, V; Fruchart, JC; Najib, J; Staels, B
      Developmental and pharmacological regulation of apolipoprotein C-II gene expression - Comparison with apo C-I and apo C-III gene regulation

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    41. Clavey, V; Copin, C; Mariotte, MC; Bauge, E; Chinetti, G; Fruchart, J; Fruchart, JC; Dallongeville, J; Staels, B
      Gels culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cells

      CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
    42. Fruchart, JC; Duriez, P; Staels, B
      Peroxisome proliferator-activated receptor-alpha activators regulate genesgoverning lipoprotein metabolism, vascular inflammation and atherosclerosis

      CURRENT OPINION IN LIPIDOLOGY
    43. Torra, IP; Gervois, P; Staels, B
      Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging

      CURRENT OPINION IN LIPIDOLOGY
    44. Neele, DM; Buytenhek, R; Staels, B; Dallongeville, J; Wallnofer, AE; Kooistra, T; Princen, HMG
      No short-term effect of oral isotretinoin (13-cis retinoic acid) on lipoprotein(a) and HDL subclasses LP-A-I and LP-A-I : A-II in healthy volunteers

      JOURNAL OF INTERNAL MEDICINE
    45. Gervois, P; Torra, IP; Chinetti, G; Grotzinger, T; Dubois, G; Fruchart, JC; Fruchart-Najib, J; Leitersdorf, E; Staels, B
      A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity

      MOLECULAR ENDOCRINOLOGY
    46. Gervois, P; Chopin-Delannoy, S; Fadel, A; Dubois, G; Kosykh, V; Fruchart, JC; Najib, J; Laudet, V; Staels, B
      Fibrates increase human REV-ERB alpha expression in liver via a novel peroxisome proliferator-activated receptor response element

      MOLECULAR ENDOCRINOLOGY
    47. Besnard, S; Mariani, J; Staels, B; Tedgui, A
      Multiple abnormalities of the staggerer mice with a mutation in the ROR alpha nuclear receptor.

      M S-MEDECINE SCIENCES
    48. Asset, G; Staels, B; Wolff, RL; Bauge, E; Madj, Z; Fruchart, JC; Dallongeville, J
      Effects of Pinus pinaster and Pinus koraiensis seed oil supplementation onlipoprotein metabolism in the rat

      LIPIDS
    49. Madsen, L; Froyland, L; Kryvi, H; Auwerx, J; Staels, B; Berge, RK
      The mitochondrion is the principal target for nutritional and pharmacological control of plasma triglyceride

      LIPIDS
    50. Raspe, E; Madsen, L; Lefebvre, AM; Leitersdorf, I; Gelman, L; Peinado-Onsurbe, J; Dallongeville, J; Fruchart, JC; Berge, R; Staels, B
      Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid (TTA) via PPAR alpha activation

      JOURNAL OF LIPID RESEARCH
    51. Delerive, P; De Bosscher, K; Besnard, S; Vanden Berghe, W; Peters, JM; Gonzalez, FJ; Fruchart, JC; Tedgui, A; Haegeman, G; Staels, B
      Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappa B and AP-1

      JOURNAL OF BIOLOGICAL CHEMISTRY
    52. Staels, B
      Nuclear receptors as targets to modulate HDL levels

      ATHEROSCLEROSIS
    53. Trottein, F; Nutten, S; Angeli, V; Delerive, P; Teissier, E; Capron, A; Staels, B; Capron, M
      Schistosoma mansoni schistosomula reduce E-selectin and VCAM-1 expression in TNF-alpha-stimulated lung microvascular endothelial cells by interferingwith the NF-kappa B pathway

      EUROPEAN JOURNAL OF IMMUNOLOGY
    54. Martin, G; Pilon, A; Albert, C; Valle, M; Hum, DW; Fruchart, JC; Najib, J; Clavey, V; Staels, B
      Comparison of expression and regulation of the high-density lipoprotein receptor SR-BI and the low-density lipoprotein receptor in human adrenocortical carcinoma NCI-H295 cells

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    55. Mallat, Z; Besnard, S; Duriez, M; Deleuze, V; Emmanuel, F; Bureau, MF; Soubrier, F; Esposito, B; Duez, H; Fievet, C; Staels, B; Duverger, N; Scherman, D; Tedgui, A
      Protective role of interleukin-10 in atherosclerosis

      CIRCULATION RESEARCH
    56. Delerive, P; Martin-Nizard, F; Chinetti, G; Trottein, F; Fruchart, JC; Najib, J; Duriez, P; Staels, B
      Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway

      CIRCULATION RESEARCH
    57. Bernard, C; Merval, R; Lebret, M; Delerive, P; Dusanter-Fourt, I; Lehoux, S; Creminon, C; Staels, B; Maclouf, J; Tedgui, A
      Oncostatin M induces interleukin-6 and cyclooxygenase-2 expression in human vascular smooth muscle cells - Synergy with interleukin-1 beta

      CIRCULATION RESEARCH
    58. Hennuyer, N; Poulain, P; Madsen, L; Berge, RK; Houdebine, LM; Branellec, D; Fruchart, JC; Fievet, C; Duverger, N; Staels, B
      Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response

      CIRCULATION
    59. Kockx, M; Gervois, PP; Poulain, P; Derudas, B; Peters, JM; Gonzalez, FJ; Princen, HMG; Kooistra, T; Staels, B
      Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha

      BLOOD
    60. Beghin, L; Capps, N; Duhal, N; Davies, J; Staels, B; Luc, G
      Metabolism of apolipoproteins AI and AII in a patient with paradoxical reduction in high-density lipoprotein due to ciprofibrate

      ANNALS OF CLINICAL BIOCHEMISTRY
    61. Sirtori, CR; Lovati, MR; Manzoni, C; Gianazza, E; Bondioli, A; Staels, B; Auwerx, J
      Reduction of serum cholesterol by soy proteins: clinical experience and potential molecular mechanisms

      NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
    62. EDGAR AD; TOMKIEWICZ C; COSTET P; LEGENDRE C; AGGERBECK M; BOUGUET J; STAELS B; GUYOMARD C; PINEAU T; BAROUKI R
      FENOFIBRATE MODIFIES TRANSAMINASE GENE-EXPRESSION VIA A PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA-DEPENDENT PATHWAY

      Toxicology letters
    63. AUWERX J; STAELS B
      LEPTIN

      Lancet
    64. STAELS B; KOENIG W; HABIB A; MERVAL R; LEBRET M; TORRA IP; DELERIVE P; FADEL A; CHINETTI G; FRUCHART JC; NAJIB J; MACLOUF J; TEDGUI A
      ACTIVATION OF HUMAN AORTIC SMOOTH-MUSCLE CELLS IS INHIBITED BY PPAR-ALPHA BUT NOT BY PPAR-GAMMA ACTIVATORS

      Nature
    65. VUDAC N; GERVOIS P; TORRA IP; FRUCHART JC; KOSYKH V; KOOISTRA T; PRINCEN HMG; DALLONGEVILLE J; STAELS B
      RETINOIDS INCREASE HUMAN APO C-III EXPRESSION AT THE TRANSCRIPTIONAL LEVEL VIA THE RETINOID-X-RECEPTOR - CONTRIBUTION TO THE HYPERTRIGLYCERIDEMIC ACTION OF RETINOIDS

      The Journal of clinical investigation
    66. CHINETTI G; GRIGLIO S; ANTONUCCI M; TORRA IP; DELERIVE P; MAJD Z; FRUCHART JC; CHAPMAN J; NAJIB J; STAELS B
      ACTIVATION OF PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA AND RECEPTOR-GAMMA INDUCES APOPTOSIS OF HUMAN MONOCYTE-DERIVED MACROPHAGES

      The Journal of biological chemistry
    67. VUDAC N; CHOPINDELANNOY S; GERVOIS P; BONNELYE E; MARTIN G; FRUCHART JC; LAUDET V; STAELS B
      THE NUCLEAR RECEPTORS PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA AND REV-ERB-ALPHA MEDIATE THE SPECIES-SPECIFIC REGULATION OF APOLIPOPROTEIN-A-I EXPRESSION BY FIBRATES

      The Journal of biological chemistry
    68. STAELS B; AUWERX J
      REGULATION OF APO A-I GENE-EXPRESSION BY FIBRATES

      Atherosclerosis (Amsterdam)
    69. MARTIN G; SCHOONJANS K; STAELS B; AUWERX J
      PPAR-GAMMA ACTIVATORS IMPROVE GLUCOSE-HOMEOSTASIS BY STIMULATING FATTY-ACID UPTAKE IN THE ADIPOCYTES

      Atherosclerosis (Amsterdam)
    70. LEFEBVRE AM; DESREUMAUX P; PAULWEBER B; STAELS B; COLOMBEL JF; AUWERX J
      HIGH-LEVEL EXPRESSION OF PPAR-GAMMA IN DIFFERENTIATED COLON EPITHELIUM

      Gastroenterology
    71. STAELS B; DALLONGEVILLE J; AUWERX J; SCHOONJANS K; LEITERSDORF E; FRUCHART JG
      MECHANISM OF ACTION OF FIBRATES ON LIPID AND LIPOPROTEIN METABOLISM

      Circulation
    72. KOCKX M; PETERS JM; GONZALES FJ; PRINCEN HMG; KOOISTRA T; STAELS B
      FIBRATES SUPPRESS FIBRINOGEN GENE-EXPRESSION IN RODENTS VIA ACTIVATION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA

      Circulation
    73. GERVOIS P; VUDAC N; CHOPINDELANNOY S; FADEL A; KOSYKH V; BONNELYE E; MARTIN G; SCHOONJANS K; FRUCHART JC; LAUDET V; STAELS B
      FIBRATES REPRESS RAT APO A-I GENE-EXPRESSION BY INCREASING REV-ERB-ALPHA EXPRESSION VIA PPAR-ALPHA INTERACTING WITH A NOVEL PPAR RESPONSE ELEMENT

      Circulation
    74. DELERIVE P; MARTIN F; CHINETTI G; TROTTEIN F; FRUCHART JC; DURIEZ P; STAELS B
      PPAR ACTIVATORS INHIBIT THROMBIN-INDUCED ENDOTHELIN-1 PRODUCTION IN HUMAN VASCULAR ENDOTHELIAL-CELLS

      Circulation
    75. DUEZ HM; MANSEN A; FRUCHART JC; VENNSTROM B; FIEVET C; STAELS B
      REV-ERB-ALPHA - A NUCLEAR RECEPTOR WITH A ROLE IN LIPOPROTEIN METABOLISM

      Circulation
    76. FLAVELL DM; PINEDATORRA I; JAMSHIDI Y; EVANS D; SYVANNE M; TASKINEN MR; HUMPHRIES SE; TALMUD PJ; STAELS B
      VARIATION IN THE PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-ALPHA GENE IS ASSOCIATED WITH PLASMA-LIPID CONCENTRATIONS, RESPONSE TO GEMFIBROZIL AND PROGRESSION OF ATHEROSCLEROSIS IN CORONARY-ARTERY BYPASS GRAFTPATIENTS

      Circulation
    77. Mamontova, A; Seguret-Mace, S; Esposito, B; Chaniale, C; Bouly, M; Delhaye-Bouchaud, N; Luc, G; Staels, B; Duverger, N; Mariani, J; Tedgui, A
      Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor ROR alpha

      CIRCULATION
    78. VANVLIJMEN BJM; PEARCE NJ; BERGO M; STAELS B; YATES JW; GRIBBLE AD; BOND BC; HOFKER MH; HAVEKES LM; GROOT PHE
      APOLIPOPROTEIN E-ASTERISK-3 LEIDEN TRANSGENIC MICE AS A TEST MODEL FOR HYPOLIPEMIC DRUGS

      Arzneimittel-Forschung
    79. LEFEBVRE AM; PEINADOONSURBE J; LEITERSDORF I; BRIGGS MR; PATERNITI JR; FRUCHART JC; FIEVET C; AUWERX J; STAELS B
      REGULATION OF LIPOPROTEIN METABOLISM BY THIAZOLIDINEDIONES OCCURS THROUGH A DISTINCT BUT COMPLEMENTARY MECHANISM RELATIVE TO FIBRATES

      Arteriosclerosis, thrombosis, and vascular biology
    80. SCHOONJANS K; MARTIN G; STAELS B; AUWERX J
      PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS, ORPHANS WITH LIGANDS ANDFUNCTIONS

      Current opinion in lipidology
    81. GELMAN L; STAELS B; AUWERX J
      ROLE OF TRANSCRIPTIONAL COFACTORS IN NUCLEAR RECEPTOR SIGNALING TRANSDUCTION

      MS. Medecine sciences
    82. FAJAS L; STAELS B; AUWERX J
      CYCLE SEQUENCING ON LARGE DNA TEMPLATES

      BioTechniques
    83. STAELS B; SCHOONJANS K; FRUCHART JC; AUWERX J
      THE EFFECTS OF FIBRATES AND THIAZOLIDINEDIONES ON PLASMA TRIGLYCERIDE-METABOLISM ARE MEDIATED BY DISTINCT PEROXISOME PROLIFERATOR ACTIVATEDRECEPTORS (PPARS)

      Biochimie
    84. FROYLAND L; MADSEN L; VAAGENES H; TOTLAND GK; AUWERX J; KRYVI H; STAELS B; BERGE RK
      MITOCHONDRION IS THE PRINCIPAL TARGET FOR NUTRITIONAL AND PHARMACOLOGICAL CONTROL OF TRIGLYCERIDE-METABOLISM

      Journal of lipid research
    85. RODRIGUEZ H; HUM DW; STAELS B; MILLER WL
      TRANSCRIPTION OF THE HUMAN GENES FOR CYTOCHROME P450SCC AND P450C17 IS REGULATED DIFFERENTLY IN HUMAN ADRENAL NCI-H295 CELLS THAN IN MOUSE ADRENAL Y1 CELLS

      The Journal of clinical endocrinology and metabolism
    86. MARTIN G; SCHOONJANS K; LEFEBVRE AM; STAELS B; AUWERX J
      COORDINATE REGULATION OF THE EXPRESSION OF THE FATTY-ACID TRANSPORT PROTEIN AND ACYL-COA SYNTHETASE GENES BY PPAR-ALPHA AND PPAR-GAMMA ACTIVATORS

      The Journal of biological chemistry
    87. PETERS JM; HENNUYER N; STAELS B; FRUCHART JC; FIEVET C; GONZALEZ FJ; AUWERX J
      ALTERATIONS IN LIPOPROTEIN METABOLISM IN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA-DEFICIENT MICE

      The Journal of biological chemistry
    88. VUDAC N; GERVOIS P; GROTZINGER T; DEVOS P; SCHOONJANS K; FRUCHART JC; AUWERX J; MARIANI J; TEDGUI A; STAELS B
      TRANSCRIPTIONAL REGULATION OF APOLIPOPROTEIN-A-I GENE-EXPRESSION BY THE NUCLEAR RECEPTOR ROR-ALPHA

      The Journal of biological chemistry
    89. FAJAS L; AUBOEUF D; RASPE E; SCHOONJANS K; LEFEBVRE AM; SALADIN R; NAJIB J; LAVILLE M; FRUCHART JC; DEEB S; VIDALPUIG A; FLIER J; BRIGGS MR; STAELS B; VIDAL H; AUWERX J
      THE ORGANIZATION, PROMOTER ANALYSIS, AND EXPRESSION OF THE HUMAN PPAR-GAMMA GENE

      The Journal of biological chemistry
    90. BERGE RK; FROYLAND L; KRYVI H; AUWERX J; STAELS B; MADSEN L
      THE MITOCHONDRION IS THE PRINCIPAL TARGET FOR NUTRITIONAL AND PHARMACOLOGICAL CONTROL OF TRIGLYCERIDE-METABOLISM

      Atherosclerosis
    91. LEFEBVRE AM; PEINADOONSURBE J; LEITERSDORF I; BRIGGS MR; PATERNITI JR; FRUCHART JC; FIEVET C; AUWERX J; STAELS B
      THIAZOLIDINEDIONES EXERT A HYPOTRIGLYCERIDEMIC EFFECT BY A DISTINCT, BUT COMPLEMENTARY MECHANISM RELATIVE TO FIBRATES

      Atherosclerosis
    92. MADSEN L; FROYLAND L; STAELS B; BERGE RK
      THE UNDERLYING MECHANISM OF THE HYPOLIPIDEMIC EFFECT OF 3-THIA FATTY-ACIDS

      Atherosclerosis
    93. NEELE DM; BUYTENHEK R; STAELS B; DALLONGEVILLE J; WALLNOFER AE; KOOISTRA T; PRINCEN HMG
      EFFECTS OF ORAL ISOTRETINOIN (13-CIS RETINOIC ACID) ON LIPOPROTEIN(A)AND HDL SUBCLASSES IPA-I AND IPA-I-A-II IN HEALTHY-VOLUNTEERS

      Atherosclerosis
    94. MARTIN G; SCHOONJANS K; LEFEBVRE AM; STAELS B; AUWERX J
      COORDINATE REGULATION OF THE EXPRESSION OF THE FATTY-ACID TRANSPORTERPROTEIN (FATP) AND ACYL COA SYNTHETASE (ACS) GENES BY PPAR-ALPHA AND PPAR-GAMMA ACTIVATORS

      Atherosclerosis
    95. MARTIN G; PILON A; ALBERT C; VALLE M; HUM DW; FRUCHART JC; AUWERX J; CLAVEY V; STAELS B
      HDL (HIGH-DENSITY-LIPOPROTEIN) AND LDL (LOW-DENSITY-LIPOPROTEIN) RECEPTORS REGULATION IN HUMAN ADRENAL-CORTEX

      Atherosclerosis
    96. STAELS B
      TRANSCRIPTION FACTOR GENES-CONTROLLING HIGH-DENSITY-LIPOPROTEIN METABOLISM

      Atherosclerosis
    97. STAELS B
      REGULATION OF APO A-I GENE-EXPRESSION BY FIBRATES

      Atherosclerosis
    98. AUWERX J; STAELS B; FRUCHART JC
      CLINICAL IMPORTANCE OF NEW INSIGHTS INTO THE MECHANISM OF ACTIVATION OF FIBRATES

      Atherosclerosis
    99. LEFEBVRE AM; PEINADOONSURBE J; LEITERSDORF I; BRIGGS MR; PATERNITI JR; FRUCHART JC; FIEVET C; AUWERX J; STAELS B
      REGULATION OF LIPOPROTEIN METABOLISM BY THIAZOLIDINE-DIONES OCCURS THROUGH A DISTINCT, BUT COMPLEMENTARY MECHANISM RELATIVE TO FIBRATES

      Atherosclerosis
    100. HENNUYER NM; PETERS JM; STAELS B; FIEVET C; GONZALEZ FJ; AUWERX J
      ROLE OF THE PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR) IN HDL METABOLISM - INSIGHTS FROM STUDIES WITH PPAR-ALPHA-DEFICIENT MICE

      Circulation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/08/20 alle ore 12:11:19